zzlangerhans’ Activity

Yesterday

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for ARNA. 9:33 PM

Apparently not.

CAPS Underperform Pitch

zzlangerhans wrote about ZAFGEN INC COM USD0.001 (ZFGN) . 9:24 PM

ZFGN Underperform

I've registered some skepticism about Zafgen before but bestowed a green thumb on the stock as a nod to the general mood of optimism regarding legitimate biotech IPO's over the past couple of years. I'm now closing the circle with a red thumb as I [more]

CAPS Underperform Pitch

zzlangerhans wrote about AVEO Pharmaceuticals, Inc. (AVEO) . 2:30 AM

AVEO Underperform

After closing yet another failed bet on Aveo, I'd be surprised if I ever went long on this stock again. Then again, I have a bad habit of repeating the same stupid mistakes over and over. Aveo is a classic value trap, where a market cap lower than [more]

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for VNDA. 1:22 AM

Shorted 1000 shares at 14.5 today, since regaining rights to Fanapt is not a positive and does not remotely justify a 20% pop in share price on a huge down day for biotech. Novartis also bought a 25M dilutive financing at 13.5, which is hard to [more]

Tue Dec 23

Caps Pick

zzlangerhans made a pick in CAPS. 2:00 PM

ZAFGEN INC COM USD0.001 (ZFGN) will Underperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 1:59 PM

JUNO THERAPEUTICS COM USD0.0001 (JUNO) will Outperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 1:58 PM

Bellicum Pharmaceuticals, Inc. (BLCM) will Outperform the S&P 500

CAPS Outperform Pitch

zzlangerhans wrote about SOPHIRIS BIO INC COM NPV (POST REV SPLIT) (SPHS) . 1:54 PM

SPHS Outperform

SPHS is the ticker symbol for Sophiris. It's also a shining example of stock market onomatopoiea as the sound of value escaping from the brokerage accounts of longs after the company reported not meeting an efficacy threshold at the 12 week interim [more]

Thu Dec 18

Caps Pick

zzlangerhans made a pick in CAPS. 10:38 AM

AVEO Pharmaceuticals, Inc. (AVEO) will Underperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 8:29 AM

SOPHIRIS BIO INC COM NPV (POST REV SPLIT) (SPHS) will Outperform the S&P 500

Sat Dec 13

Blog Comment

zzlangerhans commented on EnigmaDude's blog post. 8:19 AM

Anyone else having trouble adding/closing picks?

I'm just amazed that the site is still functional at all.

CAPS Underperform Pitch

zzlangerhans wrote about ARCA Biopharma, Inc. (ABIO) . 1:34 AM

ABIO Underperform

There's not much point rehashing the dissection of Arca I've dumped on this website countless times, with the last being just a month ago. If you really want to check the most recent version, it's here [more]

Thu Dec 11

Caps Pick

zzlangerhans made a pick in CAPS. 9:46 AM

ARCA Biopharma, Inc. (ABIO) will Underperform the S&P 500

Sun Dec 7

CAPS Outperform Pitch

zzlangerhans wrote about Sarepta Therapeutics (SRPT) . 11:06 PM

SRPT Outperform

There's no denying that Sarepta is a cult stock only rivaled by Mannkind. Similarly to Mannkind, Sarepta always seems to overshoot the rational price range in either direction depending on prevailing sentiment, and right now the wind is blowing [more]

Sat Dec 6

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for NBS. 5:28 PM

The Monday after OpEx, NeoStem issued a damage control PR: http://www.neostem.com/media/press-releases/news-item/neostem-provides-further-information-regarding-phase-2-preserve/ NeoStem starts out by saying "we are extremely disappointed, in the [more]

CAPS Outperform Pitch

zzlangerhans wrote about Neostem, Inc. (NBS) . 4:17 PM

NBS Outperform

I'm sure many people interested in stocks wonder why I would obsess over a shady microcap stem cell biotech like NeoStem. In turn, I wonder why so much stock commentary is devoted to behemoths like Apple, Tesla, and Facebook. Don't retail traders [more]

Fri Dec 5

CAPS Outperform Pitch

zzlangerhans wrote about Prothena Corporation (PRTA) . 8:16 PM

PRTA Outperform

Prothena doesn't seem to have impressed the street much with their recent announcement of positive interim data from the phase I/II trial of NEOD001 anti-amyloid mAb for amyloid light chain (AL) amyloidosis. The company reported a 50% cardiac [more]

Wed Dec 3

CAPS Outperform Pitch Reply

zzlangerhans commented on bburr4307's pitch for ATHX. 7:41 PM

So far there are 1000's of bagholders, so you were almost right.

Caps Pick

zzlangerhans made a pick in CAPS. 12:19 PM

Prothena Corporation (PRTA) will Outperform the S&P 500

Tue Dec 2

CAPS Underperform Pitch

zzlangerhans wrote about CELLCEUTIX CORP (CTIX) . 11:26 PM

CTIX Underperform

It's not easy to keep up with all the scams and cons in biopharma these days but every once in a while my kids actually go to sleep and don't wake up an hour later, and I have to make the most of it. Cellceutix is a fun one for several reasons, not [more]

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.84
Player Rank 121 out of 75073
Score 7575.25
Score Change Today +9.30
Accuracy 82.24%
Active Picks 154
Total Picks 1970
Best Pick TRIL (+1282.93)
Worst Pick PCYC (-2886.09)
Average Score per Pick 3.85
Charms Earned 15
Highest Rated Favorite usubanas
Go to zzlangerhans’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show zzlangerhans’ 10 Latest Posts